Negative selection in tumor genome evolution acts on essential cellular functions and the immunopeptidome.

In summary, our results show that negative selection is a hallmark of cell essentiality and immune response in cancer. The functional domains identified could be exploited therapeutically, ultimately allowing for the development of novel cancer treatments.